Browse Data and Analysis

Although Ecuador maintains a number of anti-biotech laws and regulations, there is minimal enforcement, and trade in cotton and soybean products continues.

Mozambique is revising its biosafety regulations, which could allow for the country's first field trials of genetically engineered crops.

Information on the Egyptian market for U.S. exporters of food and agricultural products. Prospects for U.S. bulk commodities and intermediate products remain positive in 2013.

Brazil is the world's second-largest producer of biotech crops. Post forecasts a 10-percent increase in area planted to biotech crops in the upcoming 2013/14 Brazilian crop year (October-September).

China is expected to remain a significant importer of biotech products and may become an exporter of biotechnology in the medium to long term.

Colombia continues to expand its biotechnology frontier. The adoption rate for biotech corn has surpassed that of cotton and the development of a regulatory framework is underway.

Recent high-profile activism against biotechnology has created uncertainty among those involved in production and research of biotechnology products in Costa Rica.

El Salvador has no legal restriction on the use of agricultural biotechnology. However the country's biotech regulatory framework is still being developed.

A rapidly growing middle class in North Asia is expected to boost demand for U.S. agricultural exports over the next decade.

Egypt’s cotton production is expected to decline in 2013/14 in the face of what Egyptian farmers regard as relatively low prices.

Post forecasts Brazil's 2013/14 production to increase slightly, with exports to decrease 55 percent.

A look at U.S. exports to South Korea in the year since since the United States-Korea Free Trade Agreement entered into force.